secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0001013762-25-004236
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar enters ATM equity distribution agreement for up to $75M
--------------------------------------------------------------

- ATM equity distribution agreement with Piper Sandler and BTIG allows sale of up to $75M of common stock.
- Shares sold via at-the-market offerings on Nasdaq; agents receive 3.0% commission on gross proceeds.
- Company has no obligation to sell any shares; either party may suspend or terminate the offering.
- Registration statement on Form S-3 filed on March 28, 2025, for the offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000101376225004236/0001013762-25-004236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000101376225004236/ea0236055-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001013762-25-004236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer